Indamed Pharmaceuticals Private Limited, a active private limited company, was established on 18 December 1985 in Gujarat, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232GJ1985PTC008335. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.93 M.
It upholds a compliant status. Its leadership includes Mohitkumar Rajendrakumar Patel (Director), Darshankumar Narendrabhai Sukhadeeya (Director). Past directors included Hasmukhbhai Kantilal Patel, Amratbhai Parsottamdas Patel, Nirav Bharatbhai Patel. It holds ₹10.95 Cr open charges and ₹3.64 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at Nr G I D Chigh Way Road Mansa, Gujarat, Gujarat, 382845.
U24232GJ1985PTC008335
008335
18 December 1985
₹1.00 M
₹0.93 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Indamed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohitkumar Rajendrakumar Patel | Director | 01 Dec 2018 | Current |
| Darshankumar Narendrabhai Sukhadeeya | Director | 01 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Apr 2021 | Past |
| Pramod Abcsdd | Managing Director | 28 Nov 2018 | Past |
| Pramod Abcsdd | Director | 31 May 2021 | Past |
| Pramod Abcsdd | Director | 28 Nov 2018 | Past |
| Pramod Abcsdd | Director | 05 Nov 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indamed Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 46.25% decrease. The company also saw a substantial fall in profitability, with a 55.14% decrease in profit. The company's net worth Soared by an impressive increase of 13.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Indamed Pharmaceuticals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹109,500,000.00
₹36,350,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2023 | Others | ₹10.95 Cr | Open |
| 25 Nov 2022 | Bank Of India | ₹3.50 Cr | Satisfied |
| 04 Oct 2019 | Others | ₹0.50 M | Satisfied |
| 07 Nov 1997 | The Mansa Nagar Sahkari Bank Ltd | ₹0.35 M | Satisfied |
| 07 Mar 1993 | The Mansa Nagar Sahkari Bank Ltd | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Indamed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indamed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indamed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Indamed Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was documented.
Progress on A charge with Others of Rs. 109.50 M registered on 20 Jun 2023 with Charge ID 100744856 was modified on 05 May 2025. was documented.
Indamed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge registered on 25 Nov 2022 via Charge ID 100650870 with Bank Of India was fully satisfied on 28 Jun 2023. was documented.
Progress on A charge with Others amounted to Rs. 109.50 M with Charge ID 100744856 was registered on 20 Jun 2023. was documented.
The activity A charge registered on 04 Oct 2019 via Charge ID 100293852 with Others was fully satisfied on 15 Dec 2022. was completed.
The CIN of Indamed Pharmaceuticals Private Limited is U24232GJ1985PTC008335.
Indamed Pharmaceuticals Private Limited is headquartered at Nr G I D Chigh Way Road Mansa, Gujarat, Gujarat, 382845.
Indamed Pharmaceuticals Private Limited was incorporated on 18 December 1985.
The current directors of Indamed Pharmaceuticals Private Limited are
The primary industry of Indamed Pharmaceuticals Private Limited is Manufacturing.
Indamed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Indamed Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.93 M.
The compliance status of Indamed Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX